X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
index medicus (26) 26
humans (23) 23
hematology (18) 18
multiple myeloma (16) 16
oncology (13) 13
multiple myeloma - genetics (12) 12
female (11) 11
multiple-myeloma (11) 11
male (10) 10
article (9) 9
multiple myeloma - drug therapy (9) 9
multiple myeloma - mortality (9) 9
prognosis (9) 9
aged (8) 8
cancer (8) 8
care and treatment (8) 8
middle aged (8) 8
multiple myeloma - pathology (8) 8
thalidomide (8) 8
abridged index medicus (7) 7
survival (7) 7
aged, 80 and over (6) 6
development and progression (6) 6
in-situ hybridization (6) 6
multiple myeloma - diagnosis (6) 6
stem-cell transplantation (6) 6
therapy (6) 6
adult (5) 5
gene expression (5) 5
genetic aspects (5) 5
multiple myeloma - therapy (5) 5
mutation (5) 5
myeloma (5) 5
thalidomide - therapeutic use (5) 5
translocation, genetic (5) 5
treatment outcome (5) 5
dexamethasone (4) 4
gene expression profiling (4) 4
gene-expression (4) 4
hematology, oncology and palliative medicine (4) 4
kaplan-meier estimate (4) 4
lymphoid neoplasia (4) 4
methylation (4) 4
research (4) 4
survival analysis (4) 4
thalidomide - adverse effects (4) 4
thalidomide - analogs & derivatives (4) 4
102 (3) 3
acute lymphoblastic-leukemia (3) 3
bortezomib (3) 3
cell survival (3) 3
dna (3) 3
evolution (3) 3
expression (3) 3
health aspects (3) 3
hemic and lymphatic diseases (3) 3
histones - metabolism (3) 3
international staging system (3) 3
leukemia (3) 3
patients (3) 3
phenotype (3) 3
poor-prognosis (3) 3
proteins (3) 3
refractory multiple-myeloma (3) 3
risk groups (3) 3
t myeloma (3) 3
adverse prognostic-factor (2) 2
biomarkers (2) 2
bortezomib-melphalan-prednisone (2) 2
brief report (2) 2
cell line, tumor (2) 2
cell proliferation - drug effects (2) 2
cells (2) 2
chromatin (2) 2
comorbidity (2) 2
consolidation therapy (2) 2
copy number (2) 2
dependent probe amplification (2) 2
diagnosed multiple-myeloma (2) 2
disease (2) 2
dna mutational analysis (2) 2
elderly-patients (2) 2
epigenesis, genetic (2) 2
epigenetics (2) 2
events (2) 2
follow-up studies (2) 2
gene (2) 2
gene mutations (2) 2
genetics (2) 2
health risks (2) 2
hela cells (2) 2
heterogeneity (2) 2
histone h3 (2) 2
immunoglobulin heavy chains - genetics (2) 2
immunologic factors - therapeutic use (2) 2
immunosuppressive agents - therapeutic use (2) 2
imwg consensus (2) 2
in situ hybridization, fluorescence (2) 2
inhibition (2) 2
inhibitors (2) 2
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


British Journal of Hospital Medicine, ISSN 1750-8460, 02/2019, Volume 80, Issue 2, pp. 91 - 98
Myeloma outcomes have improved dramatically over the last decade as a result of novel therapies, several of which are now commonly continued to disease... 
MULTIPLE-MYELOMA | PATHOGENESIS | SURVIVAL | MEDICINE, GENERAL & INTERNAL | MONOCLONAL GAMMOPATHY | IMWG CONSENSUS | OUTCOMES | UNDETERMINED SIGNIFICANCE MGUS
Journal Article
Blood, ISSN 0006-4971, 02/2019, Volume 133, Issue 7, pp. 660 - 675
To date, the choice of therapy for an individual multiple myeloma patient has been based on clinical factors such as age and comorbidities. The widespread... 
TARGETED THERAPY | IMPACT | POOR-PROGNOSIS | INTERNATIONAL STAGING SYSTEM | INDEPENDENT COHORT | T(4/14) | IN-SITU HYBRIDIZATION | GENE-EXPRESSION | HEMATOLOGY | MINIMAL RESIDUAL DISEASE | PROGNOSTIC VALUE | Advances in Multiple Myeloma | Review Series | 102
Journal Article
Clinical Lymphoma, Myeloma and Leukemia, ISSN 2152-2650, 10/2019, Volume 19, Issue 10, pp. e244 - e245
Journal Article
Journal Article
Journal Article
International Journal of Laboratory Hematology, ISSN 1751-5521, 09/2019
Journal Article
Blood, ISSN 0006-4971, 07/2017, Volume 130, Issue 1, pp. 30 - 34
Journal Article
Blood, ISSN 0006-4971, 12/2016, Volume 128, Issue 22, pp. 4412 - 4412
Abstract Introduction With a multifactorial mechanism of action and excellent PFS associated with prolonged exposure, lenalidomide (len) is an attractive... 
Journal Article
Blood, ISSN 0006-4971, 11/2019, Volume 134, Issue Supplement_1, pp. 1889 - 1889
Background: The impact of the selective pressure of maintenance Lenalidomide has the potential to enhance disease aggressiveness at relapse and if this were... 
Journal Article
Blood, ISSN 0006-4971, 11/2019, Volume 134, Issue Supplement_1, pp. 4374 - 4374
Introduction: Multiple myeloma (MM) is more common in men than women but the mechanism(s) driving this are not understood. In our previous study (Myeloma IX)... 
Journal Article